227 related articles for article (PubMed ID: 37395104)
21. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
[TBL] [Abstract][Full Text] [Related]
22. Microablative Fractional CO
Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M
Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867
[TBL] [Abstract][Full Text] [Related]
23. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
24. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S
Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052
[TBL] [Abstract][Full Text] [Related]
25. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy.
Cucinella L; Tiranini L; Cassani C; Martella S; Nappi RE
Int J Womens Health; 2023; 15():1261-1282. PubMed ID: 37576184
[TBL] [Abstract][Full Text] [Related]
26. The Fractional CO
Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
[TBL] [Abstract][Full Text] [Related]
27. Use of a vaginal CO
Mejia-Gomez J; Bouteaud J; Philippopoulos E; Wolfman W; Brezden-Masley C
Climacteric; 2022 Jun; 25(3):228-234. PubMed ID: 34694948
[TBL] [Abstract][Full Text] [Related]
28. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
Mothes AR; Runnebaum M; Runnebaum IB
J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Jha S; Wyld L; Krishnaswamy PH
Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
[TBL] [Abstract][Full Text] [Related]
30. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S
Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261
[TBL] [Abstract][Full Text] [Related]
31. Fractional Microablative CO
Pagano T; Travaglino A; Raffone A; Vallone R; Buonfantino C; De Rosa P; Locci M; Guadagno E; Insabato L; Salvatore S; De Placido G
Lasers Surg Med; 2021 Apr; 53(4):521-527. PubMed ID: 32797701
[TBL] [Abstract][Full Text] [Related]
32. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
[TBL] [Abstract][Full Text] [Related]
33. Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review.
D'Oria O; Giannini A; Buzzaccarini G; Tinelli A; Corrado G; Frega A; Vizza E; Caserta D
Eur J Obstet Gynecol Reprod Biol; 2022 Oct; 277():84-89. PubMed ID: 36037664
[TBL] [Abstract][Full Text] [Related]
34. Microablative fractional CO
Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
[TBL] [Abstract][Full Text] [Related]
35. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
[TBL] [Abstract][Full Text] [Related]
36. Long-term reliability of fractioned CO
Pieralli A; Bianchi C; Longinotti M; Corioni S; Auzzi N; Becorpi A; Fallani MG; Cariti G; Petraglia F
Arch Gynecol Obstet; 2017 Nov; 296(5):973-978. PubMed ID: 28866727
[TBL] [Abstract][Full Text] [Related]
37. Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
Lubián López DM
World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932
[TBL] [Abstract][Full Text] [Related]
38. Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial.
Mackova K; Mazzer AM; Mori Da Cunha M; Hajkova Hympanova L; Urbankova I; Kastelein AW; Vodegel E; Vander Linden K; Fehervary H; Guler Z; Roovers JP; Krofta L; Verhaeghe J; Deprest J
BJOG; 2021 May; 128(6):1087-1096. PubMed ID: 33017509
[TBL] [Abstract][Full Text] [Related]
39. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review.
Jugulytė N; Žukienė G; Bartkevičienė D
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676756
[TBL] [Abstract][Full Text] [Related]
40. Vaginal Rejuvenation: A Retrospective Review of Lasers and Radiofrequency Devices.
Juhász MLW; Korta DZ; Mesinkovska NA
Dermatol Surg; 2021 Apr; 47(4):489-494. PubMed ID: 33165070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
